|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nehls O, Gregor M and Klump B: Serum and
bile markers for cholangiocarcinoma. Semin Liver Dis. 24:139–154.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Patel T: Increasing incidence and
mortality of primary intrahepatic cholangiocarcinoma in the United
States. Hepatology. 33:1353–1357. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patel T: Worldwide trends in mortality
from biliary tract malignancies. BMC Cancer. 2:102002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Poultsides GA, Zhu AX, Choti MA and Pawlik
TM: Intrahepatic cholangiocarcinoma. Surg Clin North Am.
90:817–837. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cardinale V, Carpino G, Reid L, Gaudio E
and Alvaro D: Multiple cells of origin in cholangiocarcinoma
underlie biological, epidemiological and clinical heterogeneity.
World J Gastrointest Oncol. 4:94–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Harrison LE, Fong Y, Klimstra DS, Zee SY
and Blumgart LH: Surgical treatment of 32 patients with peripheral
intrahepatic cholangiocarcinoma. Br J Surg. 85:1068–1070. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yamamoto M, Takasaki K, Yoshikawa T, Ueno
K and Nakano M: Does gross appearance indicate prognosis in
intrahepatic cholangiocarcinoma? J Surg Oncol. 69:162–167. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakagohri T, Kinoshita T, Konishi M,
Takahashi S and Gotohda N: Surgical outcome and prognostic factors
in intrahepatic cholangiocarcinoma. World J Surg. 32:2675–2680.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
El-Serag HB, Engels EA, Landgren O, Chiao
E, Henderson L, Amaratunge HC and Giordano TP: Risk of
hepatobiliary and pancreatic cancers after hepatitis C virus
infection: A population-based study of U.S. veterans. Hepatology.
49:116–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Welzel TM, Graubard BI, El-Serag HB, Shaib
YH, Hsing AW, Davila JA and McGlynn KA: Risk factors for
intrahepatic and extrahepatic cholangiocarcinoma in the United
States: A population-based case-control study. Clin Gastroenterol
Hepatol. 5:1221–1228. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang F, Li L, Yang X, Wang B, Zhao J, Lu
S and Yu X: Expression and activation of EGFR and STAT3 during the
multistage carcinogenesis of intrahepatic cholangiocarcinoma
induced by 3′-methyl-4 dimethylaminoazobenzene in rats. J Toxicol
Pathol. 28:79–87. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen Y, Ma L, He Q, Zhang S, Zhang C and
Jia W: TGF-β1 expression is associated with invasion and metastasis
of intrahepatic cholangiocarcinoma. Biol Res. 48:262015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian X, Wang Q, Li Y, Hu J, Wu L, Ding Q
and Zhang C: The expression of S100A4 protein in human intrahepatic
cholangiocarcinoma: Clinicopathologic significance and prognostic
value. Pathol Oncol Res. 21:195–201. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baykov AA, Cooperman BS, Goldman A and
Lahti R: Cytoplasmic inorganic pyrophosphatase. Prog Mol Subcell
Biol. 23:127–150. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Islam MK, Miyoshi T, Yamada M and Tsuji N:
Pyrophosphatase of the roundworm Ascaris suum plays an essential
role in the worm's molting and development. Infect Immun.
73:1995–2004. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen J, Brevet A, Fromant M, Lévêque F,
Schmitter JM, Blanquet S and Plateau P: Pyrophosphatase is
essential for growth of Escherichia coli. J Bacteriol.
172:5686–5689. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kharbhih WJ and Sharma R: Age-dependent
increased expression and activity of inorganic pyrophosphatase in
the liver of male mice and its further enhancement with short- and
long-term dietary restriction. Biogerontology. 15:81–86. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Panda H, Pandey RS, Debata PR and Supakar
PC: Age-dependent differential expression and activity of rat liver
cytosolic inorganic pyrophosphatase gene. Biogerontology.
8:517–525. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen G, Gharib TG, Huang CC, Thomas DG,
Shedden KA, Taylor JM, Kardia SL, Misek DE, Giordano TJ, Iannettoni
MD, et al: Proteomic analysis of lung adenocarcinoma:
Identification of a highly expressed set of proteins in tumors.
Clin Cancer Res. 8:2298–2305. 2002.PubMed/NCBI
|
|
21
|
Hamler RL, Zhu K, Buchanan NS, Kreunin P,
Kachman MT, Miller FR and Lubman DM: A two-dimensional liquid-phase
separation method coupled with mass spectrometry for proteomic
studies of breast cancer and biomarker identification. Proteomics.
4:562–577. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chahed K, Kabbage M, Ehret-Sabatier L,
Lemaitre-Guillier C, Remadi S, Hoebeke J and Chouchane L:
Expression of fibrinogen E-fragment and fibrin E-fragment is
inhibited in the human infiltrating ductal carcinoma of the breast:
The two-dimensional electrophoresis and MALDI-TOF-mass spectrometry
analyses. Int J Oncol. 27:1425–1431. 2005.PubMed/NCBI
|
|
23
|
Megger DA, Bracht T, Kohl M, Ahrens M,
Naboulsi W, Weber F, Hoffmann AC, Stephan C, Kuhlmann K, Eisenacher
M, et al: Proteomic differences between hepatocellular carcinoma
and nontumorous liver tissue investigated by a combined gel-based
and label-free quantitative proteomics study. Mol Cell Proteomics.
12:2006–2020. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tomonaga T, Matsushita K, Yamaguchi S,
Oh-Ishi M, Kodera Y, Maeda T, Shimada H, Ochiai T and Nomura F:
Identification of altered protein expression and post-translational
modifications in primary colorectal cancer by using agarose
two-dimensional gel electrophoresis. Clin Cancer Res. 10:2007–2014.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yu WL, Cong WM, Zhang Y, Chen Y, Wang F
and Yu G: Overexpression of ATA1/SLC38A1 predicts future recurrence
and death in Chinese patients with hilar cholangiocarcinoma. J Surg
Res. 171:663–668. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen Y, Cha Z, Fang W, Qian B, Yu W, Li W,
Yu G and Gao Y: The prognostic potential and oncogenic effects of
PRR11 expression in hilar cholangiocarcinoma. Oncotarget.
6:20419–20433. 2015.PubMed/NCBI
|
|
27
|
Yu G, Yu W, Jin G, Xu D, Chen Y, Xia T, Yu
A, Fang W, Zhang X, Li Z and Xie K: PKM2 regulates neural invasion
of and predicts poor prognosis for human hilar cholangiocarcinoma.
Mol Cancer. 14:1932015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim Y, Moris DP, Zhang XF, Bagante F,
Spolverato G, Schmidt C, Dilhoff M and Pawlik TM: Evaluation of the
8th edition American joint commission on cancer (AJCC) staging
system for patients with intrahepatic cholangiocarcinoma: A
surveillance, epidemiology, and end results (SEER) analysis. J Surg
Oncol. 116:643–650. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jeong SH, Ko GH, Cho YH, Lee YJ, Cho BI,
Ha WS, Choi SK, Kim JW, Lee CW, Heo YS, et al: Pyrophosphatase
overexpression is associated with cell migration, invasion, and
poor prognosis in gastric cancer. Tumour Biol. 33:1889–1898. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sempoux C, Jibara G, Ward SC, Fan C, Qin
L, Roayaie S, Fiel MI, Schwartz M and Thung SN: Intrahepatic
cholangiocarcinoma: New insights in pathology. Semin Liver Dis.
31:49–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hyder O, Marques H, Pulitano C, Marsh JW,
Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A,
Barroso E, et al: A nomogram to predict long-term survival after
resection for intrahepatic cholangiocarcinoma: An Eastern and
Western experience. JAMA Surg. 149:432–438. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ribero D, Pinna AD, Guglielmi A, Ponti A,
Nuzzo G, Giulini SM, Aldrighetti L, Calise F, Gerunda GE, Tomatis
M, et al: Surgical approach for long-term survival of patients with
intrahepatic cholangiocarcinoma: A multi-institutional analysis of
434 patients. Arch Surg. 147:1107–1113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li YY, Li H, Lv P, Liu G, Li XR, Tian BN
and Chen DJ: Prognostic value of cirrhosis for intrahepatic
cholangiocarcinoma after surgical treatment. J Gastrointest Surg.
15:608–613. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mishra DR, Chaudhary S, Krishna BM and
Mishra SK: Identification of critical elements for regulation of
inorganic pyrophosphatase (PPA1) in MCF7 breast cancer cells. PLoS
One. 10:e01248642015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Thoma I, Loeffler C, Sinha AK, Gupta M,
Krischke M, Steffan B, Roitsch T and Mueller MJ: Cyclopentenone
isoprostanes induced by reactive oxygen species trigger defense
gene activation and phytoalexin accumulation in plants. Plant J.
34:363–375. 2003. View Article : Google Scholar : PubMed/NCBI
|
